Kenmore, WA, United States of America

Joseph Leon Kuijper

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 5.6

ph-index = 14

Forward Citations = 713(Granted Patents)


Location History:

  • Bothell, WA (US) (1998 - 1999)
  • Bagsvaerd, DK (2017 - 2018)
  • Kenmore, WA (US) (2006 - 2023)
  • Seattle, WA (US) (2022 - 2023)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):Explore Patents

Title: Innovations of Joseph Leon Kuijper in Immunomodulatory Proteins

Introduction

Joseph Leon Kuijper is a notable inventor based in Kenmore, Washington, with an impressive portfolio of 41 patents. His work primarily focuses on immunomodulatory proteins that have significant therapeutic implications for various diseases and conditions.

Latest Patents

Among his latest innovations are two remarkable patents. The first is associated with APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof. This patent describes proteins that exhibit neutralizing activity against BAFF and APRIL, including important variants of Transmembrane Activator and CAML Interactor (TACI). Notably, these proteins include TACI-Fc fusion proteins and elucidate the therapeutic utility for a range of immunological diseases and disorders. The second patent focuses on CD112 variant immunomodulatory proteins, emphasizing their utility in treating both immunological and oncological conditions. It also provides compositions and methods for the development and application of these innovative proteins.

Career Highlights

Joseph has made remarkable contributions to his field while working at renowned companies such as Zymogenetics, Inc. and Alpine Immune Sciences, Inc. His work in these organizations has paved the way for advancements in immunotherapy, enhancing the treatment options available for patients suffering from various ailments.

Collaborations

Collaboration plays a crucial role in the innovation process, and Joseph has worked alongside esteemed coworkers, including Cindy A Sprecher and Francis J Grant. Their combined efforts in research have undoubtedly contributed to the successful development of groundbreaking immunomodulatory therapies.

Conclusion

Joseph Leon Kuijper's contributions to the field of immunology through his patents highlight his innovative spirit and dedication to enhancing healthcare solutions. With a robust portfolio and a commitment to research and collaboration, he continues to pave the way for future advancements in the treatment of immunological and oncological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…